When it comes to prescriptions, knowing you're taking the right drug at the right dose is essential. But a recent recall involving a commonly prescribed blood pressure medication points out an unexpected concern: the potential presence of "foreign tablets."
Advagen Pharma Limited of East Windsor, New Jersey, is recalling 3,684 bottles of 50-mg metoprolol tartrate tablets because they may contain foreign tablets/capsules, meaning pills that do not belong in the medication's packaging. However, the report does not specify what the foreign tablets/capsules were in this case.
As of November 10, the U.S. Food and Drug Administration (FDA) has recognized the recall as Class II, indicating that use of the recalled drug may cause temporary health consequences, but the probability of a serious health issue is remote.
